CD21 and FCRL5 form a receptor complex with robust B-cell activating capacity.

Franco, Andrea; Kraus, Zachary; Li, Huifang; Seibert, Naomi; Dement-Brown, Jessica; Tolnay, Mate

Franco, Andrea; Kraus, Zachary; Li, Huifang; Seibert, Naomi; Dement-Brown, Jessica; Tolnay, Mate.

Afiliación

Franco A; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
Kraus Z; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
Li H; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
Seibert N; Fina Biosolutions LLC, Rockville, MD, USA.
Dement-Brown J; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
Tolnay M; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.

Int Immunol ; 30(12): 569-578, 2018 11 14.

Article en En | MEDLINE | ID: mdl-30107486

Asunto(s)

Linfocitos B/inmunología; Receptores de Complemento 3d/inmunología; Receptores Fc/inmunología; Linfocitos B/citología; Complemento C3/inmunología; Humanos; Inmunoglobulina G/inmunología; Transducción de Señal/inmunología

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos B / Receptores Fc / Receptores de Complemento 3d Límite: Humans Idioma: En Revista: Int Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google